BUSINESS REGISTRATION NUMBER
BRN 78368501
Live

Jingze Biopharmaceutical (Hefei) Co., Ltd

景澤生物醫藥(合肥)股份有限公司

Registry Verified: 2026-11-16
Jurisdiction: Hong Kong, China

Jingze Biopharmaceutical (Hefei) Co., Ltd (景澤生物醫藥(合肥)股份有限公司) is an active (Live) non-Hong Kong company, registered in Hong Kong on 2025-06-26 (operating for 1 year and 4 months). Its Business Registration Number (BRN) is 78368501, registered under Part 16 of the Companies Ordinance (Cap. 622). In its statutory filings, the latest Annual Return (Form NN3) on record was filed on 2026-07-15 (annual 42-day statutory filing window: Jun 26 – Aug 07); a total of 18 statutory filings (spanning 2025–2026, latest filed on 2026-07-15) are indexed in the registry, comprising 1 Annual Return(s) (NN3), 2 officer/secretary change notice(s) (NN6/NN7), 1 registered office change(s) (NN9).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name 景澤生物醫藥(合肥)股份有限公司 Official English Name Jingze Biopharmaceutical (Hefei) Co., Ltd
Non-HK Company Reg No. (CRN) — (No CRN Registered) Business Reg No. (BRN / UBI)
78368501
HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN
Registration Date in HK 2025-06-26 Company Category Registered Non-Hong Kong Company
Current Legal Status Live Statutory Filing Cycle
2027-06-26(2026 Return Filed)
Principal Place of Business in HK
Address maintained in statutory filings (NN3/NN1). Available via Registry extract.
Significant Controllers (SCR) Not applicable — Exempt under Cap. 622 Part 12 Div. 2A (Registered Non-Hong Kong Company; ownership disclosure governed by jurisdiction of incorporation).

II. Registered Non-Hong Kong Company Document Retrieval(Annual Return NN3 / Constitutive Documents / NN7 / CTC)

#Filing DateDocument No.Document NamePagesTariffAction
12026-07-1522702934816
NN3
Annual Return (2026) (Chinese)Latest Annual Return & Officers
15HK$ 28
22026-02-2024002049886
DOC
Amended Constitutional Document Regulating the Company (Chinese)
52HK$ 20
32026-02-2024002049885
NN5
Return of Change in the Charter, Statutes or Memorandum etc. (Chinese)
54HK$ 33
42026-01-1424002020896
DOC
Amended Constitutional Document Regulating the Company (Chinese)
51HK$ 20
52026-01-1424002020895
NN5
Return of Change in the Charter, Statutes or Memorandum etc. (Chinese)
53HK$ 33
62026-01-1424002020893
NN6
Return of Change of Company Secretary and Director (Chinese)
5HK$ 20
72026-01-1424002020892
NN7
Return of Change in Particulars of Company Secretary and Director (Chinese)
9HK$ 20
82026-01-1424002020891
NN9
Return of Change of Address (English)
2HK$ 20
92025-10-0224001939459
DOC
Amended Constitutional Document Regulating the Company (Chinese)
49HK$ 20
102025-10-0224001939458
NN5
Return of Change in the Charter, Statutes or Memorandum etc. (Chinese)
51HK$ 33

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Non-HK Company Core Dossier & Legal Status FAQ

Current Hong Kong registered address on file: [Hong Kong registered office on file — sign in free to unlock full street address]. Official registry dossiers document 1 historical registered office address change filing(s) (Form NN9).

Jingze Biopharmaceutical (Hefei) Co., Ltd is incorporated outside Hong Kong and registered in Hong Kong under Part 16 of Cap. 622 (Filings: Form NN1, NN3, NN8 authorised representative). Official index holds 18 statutory filing(s).

V. Similar Trade Names & Industry Directory

Retrieve Filings